Browse content
Table of contents
Actions for selected chapters
- Full text access
- Book chapterNo access
CHAPTER I - PHARMACOLOGY OF CANCER CHEMOTHERAPY
Pages 13-34 - Book chapterNo access
CHAPTER II - ALKYLATING AGENTS
Pages 35-93 - Book chapterNo access
CHAPTER III - METHOTREXATE
Pages 94-110 - Book chapterNo access
CHAPTER IV - 6-MERCAPTOPURINE
Pages 111-119 - Book chapterNo access
CHAPTER V - 5-FLUOROURACIL
Pages 120-128 - Book chapterNo access
CHAPTER VI - VINCA ROSEA ALKALOIDS
Pages 129-143 - Book chapterNo access
CHAPTER VII - ACTINOMYCIN D
Pages 144-148 - Book chapterNo access
CHAPTER VIII - MISCELLANEOUS AGENTS AND TECHNIQUES
Pages 149-158 - Book chapterNo access
CHAPTER IX - HORMONE THERAPY
Pages 159-170 - Book chapterNo access
CHAPTER X - SPECIAL PROBLEMS IN TOXICITY
Pages 171-184 - Book chapterNo access
CHAPTER XI - CHEMOTHERAPY OF SPECIFIC MALIGNANCIES
Pages 185-201 - Book chapterNo access
INDEX
Pages 203-215
About the book
Description
Cancer Chemotherapy: Medical Outline Series discusses the benefits and risks of cancer chemotherapy. This book is composed of 11 chapters that cover the pharmacologic and therapeutic potentials of some chemotherapeutic agents. The opening chapter briefly considers the pharmacology of cancer chemotherapy. Considerable chapters are devoted to some cancer chemotherapeutic agents, including alkylating agents, methotrexate, 6-mercaptopurine, 5-fluorouracil, and Vinca rosea alkaloids. Each chapter examines the indications, dosage, toxicity, physiology, chemistry, and pharmacology of the agents. The final chapter covers the various tumors, and the agent or agents of choice for each tumor. This book will prove useful to internists, surgeons, clinicians, and general practitioners who have had some formal training or supervised experience with chemotherapy.
Cancer Chemotherapy: Medical Outline Series discusses the benefits and risks of cancer chemotherapy. This book is composed of 11 chapters that cover the pharmacologic and therapeutic potentials of some chemotherapeutic agents. The opening chapter briefly considers the pharmacology of cancer chemotherapy. Considerable chapters are devoted to some cancer chemotherapeutic agents, including alkylating agents, methotrexate, 6-mercaptopurine, 5-fluorouracil, and Vinca rosea alkaloids. Each chapter examines the indications, dosage, toxicity, physiology, chemistry, and pharmacology of the agents. The final chapter covers the various tumors, and the agent or agents of choice for each tumor. This book will prove useful to internists, surgeons, clinicians, and general practitioners who have had some formal training or supervised experience with chemotherapy.
Details
ISBN
978-1-4832-1346-0
Language
English
Published
1967
Copyright
Copyright © 1967 Elsevier Ltd. All rights reserved.
Imprint
Butterworth-Heinemann